Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
Go back to Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock| (NASDAQ: VRDN) | Delayed: 17.57 -0.06 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.63 | 52 Week High | $ | |||
| Open | $17.29 | 52 Week Low | $ | |||
| Day High | $17.72 | P/E | N/A | |||
| Day Low | $17.29 | EPS | $ | |||
| Volume | 123,736 | |||||
